Recombinant Human TRAIL R4/TNFRSF10D Protein,His-Avi Tag

Scan for product

HEK293表达系统抗体药物靶点蛋白

Product no.93834ES Sizes3 options SourceYeasen · Official

Cat. No. 93834ES60

现货 $4,445.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

93834ES60 100 μg $4,445.00 现货 Enquire

93834ES76 500 μg $14,855.00 现货 Enquire

93834ES25 25 μg $1,215.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No93834ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293表达系统

应用方法 抗体药物靶点蛋白靶点研究和药物筛选

适用物种种属 Human

检测方法 SDS-PAGE HPLC LAL法 ELISA SPR

生物特性参数 蛋白类型重组蛋白 种属来源Human 生物活性描述【ELISA Data】Immobilized Human TRAIL No Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Human TRAIL R4 His Tag with the EC50 of 76.1ng/ml determined by ELISA.【SPR Data】Human TRAIL R4 His Tag immobilized on CM5 Chip can bind Human TRAIL No Tag with an affinity constant of 0.13 nM as determined in SPR assay. 应用抗体药物靶点蛋白 产品别称CD264 RSF10D TRAILR4 DCR2 TRUNDD TNFRSF10D

技术参数纯度>95% as determined by SDS-PAGE and HPLC. 内毒素水平<1.0 EU per μg by the LAL method. 分子量The protein has a predicted MW of 19.4 kDa. Due to glycosylation the protein migrates to 38-45 kDa based on Tris-Bis PAGE result. 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization. 活性EC50 of 76.1ng/ml determined by ELISA; affinity constant of 0.13 nM determined by SPR. 储存条件-25 ~ -15℃保存，收到货之后有效期1年。复溶后，无菌条件下，-85 ~ -65℃保存，3个月有效期。 表达系统HEK293 标签C-His-Avi 表达序列Ala56-His211 外观Lyophilized Powder 蛋白数据库编号Q9UBN6 复溶方法开盖之前，先离心。使用蒸馏水复溶冻干的蛋白质，复溶浓度超过100 μg/mL。建议首次使用时将蛋白分装为每次实验用量，避免反复冻融。